Ceftizoxime Pregnancy and Breastfeeding Warnings
Brand names: Cefizox
Ceftizoxime Pregnancy Warnings
Ceftizoxime has been assigned to pregnancy category B by the FDA. Animal data failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Ceftizoxime should only be given during pregnancy when need has been clearly established.
Ceftizoxime Breastfeeding Warnings
Ceftizoxime is excreted into human milk in small amounts. Adverse effects in the nursing infant are unlikely. Other cephalosporins have been classified as compatible with breast-feeding by the American Academy of Pediatrics.
See also
References for pregnancy information
- (2002) "Product Information. Cefizox (ceftizoxime)." Fujisawa
- Heikkila A, Erkkola R (1994) "Review of beta-lactam antibiotics in pregnancy - the need for adjustment of dosage schedules." Clin Pharmacokinet, 27, p. 49-62
References for breastfeeding information
- Gerding DN, Peterson LR (1982) "Comparative tissue and extravascular fluid concentrations of ceftizoxime." J Antimicrob Chemother, 10, p. 105-16
- (2002) "Product Information. Cefizox (ceftizoxime)." Fujisawa
- Briggs GG, Freeman RK, Yaffe SJ.. (1998) "Drugs in Pregnancy and Lactation." Baltimore, MD: Williams & Wilkins
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
